Boustead APEX Completes Multi-City China IPO Conference Tour: Shenzhen, Beijing, and Shanghai Shanghai, China — 15 Aug 2025 — Boustead APEX, Inc., Asia’s leading U.S. IPO advisory firm, together with its strategic partners including the China Centre for Promoting SME Cooperation and Development (中小企业合作发展促进中心) and international law firm Loeb & Loeb LLP, has successfully completed several major stops of its inaugural China Multi-City IPO Conference including Shenzhen, Beijing, and Shanghai. The conference series marks the first large-scale initiative in which U.S. IPO specialists traveled to multiple Chinese cities to engage directly with local entrepreneurs, founders, and investors. The events showcased strategies for accessing the U.S. capital markets — the largest in the world — and provided invaluable insights for Chinese enterprises seeking international growth. Shenzhen: Opening the Dialogue The tour kicked off in Shenzhen, where discussions centered on supply chain finance as a transformative pathway for high-valuation U.S. listings. The event convened entrepreneurs, investors, and market experts, setting the tone for a nationwide exploration of U.S. IPO opportunities. Beijing: Legal and Strategic Preparation The second stop in Beijing was co-hosted with Loeb & Loeb LLP, a premier international law firm. Attendees heard directly from seasoned professionals who have successfully brought over 600 companies to IPO in the U.S. Panel discussions highlighted key requirements and preparation for U.S. listings, while interactive sessions engaged the audience in strategies and tactics essential to IPO success. Shanghai: High-Potential Companies Identified The third stop in Shanghai was co-organized with the China Centre for Promoting SME Cooperation and Development. The event attracted founders, entrepreneurs, and executive program students from Fudan University, reflecting the city’s vibrant innovation ecosystem. From a competitive pitching session, three companies were selected as having the strongest potential for U.S. listings, impressing judges with their innovative business models and growth strategies. “Our multi-city IPO Conference has demonstrated the tremendous interest among Chinese enterprises in accessing U.S. capital markets,” said Keith Moore, Executive Director of Boustead & Company. “Through this platform, we are connecting China’s next generation of high-growth companies with the expertise and resources required to succeed in the world’s deepest capital market.” “There are many very attractive investment opportunities among the companies we’ve met on this tour,” said Dr. Charlie In, Founder of Raffles Capital and cornerstone investor of the China Multi-City IPO Tour. “With our acceleration guidance and financial support, these promising entrepreneurs can be IPO-ready much sooner than they expect.” “As host of the China Multi-City IPO Conference, we are proud to see so many dynamic founders and entrepreneurs eager to embrace the opportunities of the U.S. markets,” said Dr. Marcuz Tan, CEO of Boustead APEX, Inc. “Our goal is to provide them with the tools, knowledge, and pathways to transform their growth ambitions into successful listings that resonate with global investors.” The China Multi-City IPO Conference will continue with additional stops, further extending its mission to equip Chinese enterprises with the knowledge, resources, and global connections needed to achieve successful U.S. listings. Forward-Looking Statements This release contains forward-looking statements, including potential benefits of supply chain finance, possible valuation outcomes, and indicative timelines for U.S. listings. These statements are based on management’s current expectations and involve risks and uncertainties that could cause actual results to differ materially. No assurance can be given that any particular result will be achieved. Factors that could affect outcomes include market conditions, regulatory approvals, the company’s financial performance, and other risks described in company disclosures. Readers should not place undue reliance on forward-looking statements and should consult qualified professional advisors. About Boustead APEX, Inc. Boustead APEX, Inc. “BAI” provides corporate advisory services including but not limited to private-to-public listing strategy, mergers and acquisition deal structuring consultation, up-valuation and up-listing of undervalued companies. About Boustead & Company Limited Boustead & Company Limited is a diversified financial services firm headquartered in Irvine, CA with offices in Austin, Boca Raton, San Francisco, New York, Beijing, London, Mauritius, Monaco, Singapore, and Zug. Boustead & Company Limited and its affiliates offer mergers & acquisitions, capital markets, project finance, pre-transaction advisory, financial restructuring, sales & trading, crowdfunding, and business valuation services to emerging growth and middle-market companies. About Raffles Capital US Raffles Capital US acts as venture-accelerator for promising firms that are ready and qualifies for a public listing on a North-America bourse within 18-24 months of vesting. RC works with companies that can deliver social impact bringing prosperity and progress to the people and planet. These firms’ purpose must be in alignment with the UN 17 Sustainable Development Goals. Media Contact: Faralynn Wong Boustead APEX, Inc. mani@bousteadapex.com 即时发布 上海IPO大会聚焦高潜力企业赴美上市 中国上海 — [2023年8月15日] — 宝德亚太有限公司（Boustead APEX, Inc.）携手中小企业合作发展促进中心在上海成功举办中国多城IPO大会。此次大会汇聚了企业家、投资人以及美国IPO专家，共同探讨中国企业通过赴美上市筹集资金的发展路径与战略。 继深圳和北京站之后，上海站成为本次中国多城巡回IPO大会的重要一站。这也是美国IPO专家首次大规模走进中国多个城市，与本土企业家面对面交流，分享赴美资本市场的经验与机会。大会现场吸引了众多企业创始人和创业者参会，其中包括来自复旦大学高管项目的学生，充分体现了上海作为创新与创业中心的活力。 在本次大会的路演环节中，三家企业脱颖而出，凭借创新的商业模式和清晰的增长战略，赢得评审团的高度认可与高分评价，被评为最具赴美上市潜力的优秀企业。 “上海站的成功举办，展现了中国企业对进入全球资本市场的强烈需求。” 宝德亚太公司首席执行官陈琛傑博士（Dr. Marcuz Tan）表示，“我们很荣幸能够搭建这一平台，让企业家直接与美国市场专家交流，并将自身潜力展示在国际舞台上。” 莱福士资本创始人 殷生博士Dr. Charlie In 表示： “通过与中小企业合作发展促进中心合作，我们很高兴能聆听到许多年轻且极具潜力的创业者的分享，并深入了解他们的项目。在我们的加速和资金支持下，他们很快就能做好IPO准备。” 随着上海站的圆满落幕，中国多城IPO大会将继续前行，为更多中国中小企业提供学习、对接和拓展海外资本市场的独特机遇。 关于宝德亚太公司 宝德亚太公司及其附属机构专注于协助高增长的亚洲企业，通过战略上市、并购顾问及资本筹集方案进入美国资本市场。 关于莱福士资本（Raffles Capital US） 美国莱福士资本是一家专注于高影响力、可持续发展的私人投资集团，担任精选IPO及全球扩张项目的基石投资者。 关于中小企业合作发展促进中心 中小企业合作发展促进中心（以下简称“中心”）前身是1982年国务院经济体制改革委员会设立的中小企业国际合作促进会，2001年依据《事业单位登记管理暂行条例》经中央机构编制委员会办公室国家事业单位登记管理局登记为事业单位法人。中心是公益服务性的事业单位，是全国中小企业服务体系的核心成员单位之一。 媒体联络： Faralynn Wong 宝德亚太公司 mani@bousteadapex.com 上海IPO大会聚焦高潜力企业赴美上市 1、证券之星：https://finance.stockstar.com/IG2025082500015019.shtml 2、界面新闻：https://www.jiemian.com/article/13236333.html 3、中金在线：http://3g.cnfol.com/news/shangyeyaowen/20250825/31574795.shtml 4、凤凰财经：https://finance.ifeng.com/c/8m6gDwTJLwp 5、和讯新闻：http://news.hexun.com/2025-08-25/221091583.html 6、财经网：http://industry.caijing.com.cn/20250825/5109127.shtml 7、中国财富网：https://www.cfbond.com/2025/08/25/991100260.html 8、新浪财经：https://finance.sina.cn/2025-08-25/detail-infnesif9129281.d.html

FOR IMMEDIATE RELEASE Beijing IPO Conference Highlights Pathways for Chinese Companies to Access U.S. Capital Markets Beijing, China — 15 Aug 2025 — Boustead APEX, Inc., in collaboration with international law firm Loeb & Loeb LLP, successfully hosted the Beijing stop of its China-wide IPO Conference series. The event brought together founders and entrepreneurs from Shanghai and beyond, all eager to explore opportunities to publicly list in the United States and raise funds in the world’s largest capital market. Participants gained direct insights from seasoned U.S. IPO experts, including professionals with a track record of bringing more than 600 companies to successful listings on U.S. exchanges. The sessions provided practical knowledge, actionable guidance, and valuable networking opportunities for Chinese enterprises with global ambitions. A highlight of the Beijing conference was its expert panel discussions. One panel explored the requirements and preparations essential for pursuing a public listing in the United States, guiding entrepreneurs on compliance, governance, and readiness strategies. Another panel engaged the audience in an interactive discussion on IPO strategies and tactics, offering real-world perspectives on navigating the complexities of international capital markets. “The Beijing event showcased the depth of interest among Chinese entrepreneurs in leveraging U.S. markets for growth,” said Dr. Marcuz Tan, CEO, Boustead APEX. “By partnering with leading advisors such as Loeb & Loeb, we are equipping enterprises with the knowledge and confidence to succeed on the global stage.” With Beijing concluded, the multi-city IPO Conference now heads to Shanghai, continuing its mission to connect Chinese enterprises with the expertise and resources required to achieve successful U.S. listings. Forward-Looking Statements This release contains forward-looking statements, including potential benefits of supply chain finance, possible valuation outcomes, and indicative timelines for U.S. listings. These statements are based on management’s current expectations and involve risks and uncertainties that could cause actual results to differ materially. No assurance can be given that any particular result will be achieved. Factors that could affect outcomes include market conditions, regulatory approvals, the company’s financial performance, and other risks described in company disclosures. Readers should not place undue reliance on forward-looking statements and should consult qualified professional advisors. About Boustead APEX, Inc. Boustead APEX, Inc. “BAI” provides corporate advisory services including but not limited to private-to-public listing strategy, mergers and acquisition deal structuring consultation, up-valuation and up-listing of undervalued companies. About Loeb & Loeb LLP Loeb & Loeb LLP is a premier international law firm with deep expertise in corporate, finance, and capital markets transactions, supporting clients across the globe in achieving their strategic business objectives. Media Contact: Faralynn Wong Boustead APEX, Inc. mani@bousteadapex.com 即时发布 北京IPO大会聚焦中国企业赴美上市路径 中国北京 — [2025年8月15日] — 宝德亚太（Boustead APEX, Inc.）携手国际知名律师事务所乐博律师事务所（Loeb & Loeb LLP），在北京成功举办中国多城IPO大会。此次活动吸引了来自上海及全国的企业创始人和创业者，共同探讨如何通过赴美上市进入全球最大资本市场，拓展融资渠道。 与会者有机会直接聆听经验丰富的美国IPO专家的分享，其中包括曾成功推动600多家公司在美国上市的专业人士。大会不仅提供了前沿资讯与实战经验，也为有志于国际化发展的中国企业搭建了宝贵的交流与对接平台。 北京站的大会设置了两大亮点论坛。一场论坛聚焦于企业赴美上市的条件与准备工作，深入解读合规、治理与上市准备的关键要点；另一场论坛则围绕IPO战略与战术展开，与听众进行积极互动，分享如何在国际资本市场中成功运作的实用策略。 “北京站充分体现了中国企业对赴美资本市场的高度兴趣与热情。” 宝德亚太公司首席执行官陈琛傑博士（Dr. Marcuz Tan）表示，“通过与乐博律师事务所等顶尖顾问机构合作，我们为企业提供知识与信心，助力其走向国际舞台。” “有许多极具吸引力的投资项目，在我们的加速指导下，它们完全可以做好IPO准备。” - 莱福士资本创始人 殷生博士Dr. Charlie In 随着北京站的圆满结束，中国多城IPO大会即将启程上海站，继续为更多中国企业对接全球资本市场提供专业支持与发展机遇。 媒体联络： Faralynn Wong 宝德亚太公司 Mani@bousteadapex.com 关于宝德亚太（Boustead APEX, Inc.） 宝德亚太有限公司是亚洲领先的赴美上市顾问，致力于为高速成长的企业提供全方位支持，助力其进入美国资本市场。 关于乐博律师事务所（Loeb & Loeb LLP） 乐博律师事务所是一家国际知名的律师事务所，专注于企业、金融及资本市场交易领域，为全球客户实现战略目标提供专业支持。 关于莱福士资本（Raffles Capital US） 美国莱福士资本是一家专注于高影响力、可持续发展的私人投资集团，担任精选IPO及全球扩张项目的基石投资者。 Media Report: 北京IPO大会聚焦中国企业赴美上市路径 1、中金在线：http://hy.stock.cnfol.com/hangyejingcui/20250822/31569197.shtml 2、新浪财经：https://k.sina.com.cn/article_5953189932_162d6782c067032qv4.html 3、证券之星：https://finance.stockstar.com/IG2025082200022413.shtml 4、中国财富网：https://www.cfbond.com/2025/08/22/991100051.html 5、凤凰财经：https://finance.ifeng.com/c/8m1mBx9KWpg 6、界面新闻：https://www.jiemian.com/article/13223529.html 7、和讯新闻：http://news.hexun.com/2025-08-22/221053368.html 8、财经网：http://industry.caijing.com.cn/20250822/5108775.shtml

FOR IMMEDIATE RELEASE Regen Health Care Group Partners with Boustead APEX, Boustead & Co, and Raffles Capital US to Pursue U.S. Listing, Driving Global Expansion of Stem Cell Regeneration Therapies Shenzhen, China – 9 Aug 2025 – Regen Health Care Group, a leading provider of advanced stem cell regeneration therapies, announced today its strategic partnership with Boustead APEX, Inc., Boustead & Co, and cornerstone investor Raffles Capital US to bring the company public in the United States. This milestone marks not only a critical breakthrough in Regen’s global expansion strategy but also underscores the rising prominence of Asia’s cutting-edge regenerative medicine sector on the international stage. Over the past decade, the global regenerative medicine industry has rapidly transitioned from laboratory research to clinical application, with stem cell therapies emerging as one of its most disruptive innovations. Leveraging years of expertise in stem cell research, clinical validation, and large-scale application, Regen has built a strong medical network and brand reputation across Asia. The planned U.S. listing will provide substantial capital infusion, an international governance framework, and trust from leading global investors. As the world faces accelerating population aging and rising prevalence of chronic and degenerative diseases, the demand for advanced regenerative therapies is growing exponentially. Partnering with Boustead APEX, Boustead & Co, and Raffles Capital US, Regen aims to leverage a U.S. public listing to strengthen its R&D capabilities, expand its range of clinical indications, and deepen collaboration with top-tier international research institutions and healthcare networks, ensuring that its innovations reach patients faster. Keith Moore, Executive Chairman of Boustead & Co, stated: "Regen Health Care Group represents the type of high-growth, transformative company we are proud to support in the U.S. capital markets. The demand for advanced regenerative medicine is growing exponentially, and a U.S. listing will give Regen the platform and resources needed to lead this industry globally." Dr. Marcuz Tan, CEO of Boustead APEX, Inc., commented: "Our role is to empower visionary companies like Regen to reach the world stage without compromising on their mission or control. By leveraging our listing expertise and U.S. capital market network, we are confident that Regen will achieve a valuation that reflects its true market potential and scientific excellence." Dr. Charlie In, Founder of Raffles Capital US, said: "As the cornerstone investor in this partnership, we firmly believe in Regen’s technical capabilities and market potential in regenerative medicine. With the support of the U.S. capital markets, Regen will be able to accelerate the commercialization of its technology and expand its international footprint, bringing life-changing treatments to patients worldwide." Li Jing, CEO of Regen Health Care Group, added: "For years, our team has been dedicated to advancing cell regeneration therapy to improve lives. Partnering with Boustead APEX, Boustead & Co, and Raffles Capital US gives us the ideal platform to share our breakthroughs with the world and deliver hope to more patients globally." This partnership highlights the deepening synergy between Asia’s healthcare innovators and the liquidity, investor base, and prestige of the U.S. capital markets. The transaction is expected to begin with an OTCQB listing, with a planned uplisting to NASDAQ or NYSE within 12–18 months. About Boustead APEX, Inc. Boustead APEX, Inc. “BAI” provides corporate advisory services including but not limited to private-to-public listing strategy, mergers and acquisition deal structuring consultation, up-valuation and up-listing of undervalued companies. About Boustead & Company Limited Boustead & Company Limited is a diversified financial services firm headquartered in Irvine, CA with offices in Austin, Boca Raton, San Francisco, New York, Beijing, London, Mauritius, Monaco, Singapore, and Zug. Boustead & Company Limited and its affiliates offer mergers & acquisitions, capital markets, project finance, pre-transaction advisory, financial restructuring, sales & trading, crowdfunding, and business valuation services to emerging growth and middle-market companies. About Raffles Capital US Raffles Capital US acts as venture-accelerator for promising firms that are ready and qualifies for a public listing on a North-America bourse within 18-24 months of vesting. RC works with companies that can deliver social impact bringing prosperity and progress to the people and planet. These firms’ purpose must be in alignment with the UN 17 Sustainable Development Goals. About Regen Health Care Group Regen Health Care Group is a leading provider of stem cell regeneration therapy, offering scientifically validated treatments designed to restore and repair damaged tissues and improve quality of life. Based in Shenzhen, China, Regen serves patients across Asia and is committed to advancing research in regenerative medicine. Forward-Looking Statements This release contains forward-looking statements, including potential benefits of supply chain finance, possible valuation outcomes, and indicative timelines for U.S. listings. These statements are based on management’s current expectations and involve risks and uncertainties that could cause actual results to differ materially. No assurance can be given that any particular result will be achieved. Factors that could affect outcomes include market conditions, regulatory approvals, the company’s financial performance, and other risks described in company disclosures. Readers should not place undue reliance on forward-looking statements and should consult qualified professional advisors. Media Report: 丽晶医疗集团携手宝德亚太、宝德投行及莱福士资本 推动赴美上市，加速干细胞再生疗法全球化进程 1、中金在线：http://news.cnfol.com/shangyeyaowen/20250822/31569066.shtml 2、凤凰财经：https://finance.ifeng.com/c/8m1g9arhBX1 3、和讯新闻：http://news.hexun.com/2025-08-22/221052636.html 4、财经网：http://industry.caijing.com.cn/20250822/5108760.shtml 5、界面新闻：https://www.jiemian.com/article/13223059.html 6、证券之星：https://finance.stockstar.com/IG2025082200022384.shtml 7、中国财富网https://www.cfbond.com/2025/08/22/991100064.html

FOR IMMEDIATE RELEASE Boustead APEX Holds 2nd Shenzhen IPO Conference, Highlighting How Asian Companies Can Navigate the World’s Largest Capital Market with Ease Shenzhen, China — August 11, 2025 — Boustead APEX, Inc., in partnership with Wan Yi Group, successfully hosted the 2nd Shenzhen IPO Conference (IPOC), attracting over 80 high-growth companies from Shenzhen eager to explore opportunities in the U.S. capital markets. The event brought together leading experts, underwriters, investors, and legal professionals to discuss how Asian companies can efficiently list and thrive on the NYSE and NASDAQ. The conference opened with a keynote address from Keith Moore, Chairman of Boustead & Co, who outlined the clear and achievable requirements for U.S. main-board listings — 400 shareholders and USD 750,000 in profits — and shared strategies for maximizing valuations while preserving founder equity. Panel discussions and presentations explored practical pathways for companies, including: •Step-by-Step IPO Roadmap – From profitability to OTCQB, then uplisting to NASDAQ/NYSE within 18–24 months. •Valuation Enhancement Strategies – Using trade finance, corporate restructuring, and U.S. PCAOB audits to boost P/E multiples. •Investor Relations Best Practices – Building credibility with U.S. investors and avoiding common pitfalls in cross-border communications. •Legal Compliance and Governance – Key considerations from both U.S. and Chinese legal perspectives. In the second half of the event, 10 shortlisted companies pitched to a panel of experts for the chance to be selected for the grand finale in New York City this November, where they will present to a global audience of investors and vie for potential funding. Dr. Marcuz Tan (陳琛傑博士), CEO of Boustead APEX, Inc., commented: "Our partnership with Wan Yi Group allows us to connect directly with some of Shenzhen’s most ambitious companies. This conference provides them not just with theory, but with a concrete execution plan to access the U.S. capital markets efficiently and profitably." Dr. Charlie In, Founder of Raffles Capital and Guest of Honor, emphasized: "As a cornerstone investor, my priority is ensuring that the companies I back have a clear and rewarding exit strategy. Partnering with Boustead ensures that these investments have a proven pathway to the U.S. markets via IPO — delivering both liquidity and long-term value creation." Keith Moore, Chairman of Boustead & Co, added: "Through Boustead’s expertise, companies can approach the U.S. markets with clarity, confidence, and efficiency. Our role is to make the path to a U.S. listing straightforward while maximizing valuation and preserving founder equity." Boustead APEX reaffirmed its commitment to guiding Asian companies through every stage of the listing journey — from initial structuring and financing to ringing the bell on Wall Street. Forward-Looking Statements This release contains forward-looking statements, including potential benefits of supply chain finance, possible valuation outcomes, and indicative timelines for U.S. listings. These statements are based on management’s current expectations and involve risks and uncertainties that could cause actual results to differ materially. No assurance can be given that any particular result will be achieved. Factors that could affect outcomes include market conditions, regulatory approvals, the company’s financial performance, and other risks described in company disclosures. Readers should not place undue reliance on forward-looking statements and should consult qualified professional advisors. About Boustead APEX, Inc. Boustead APEX, Inc. “BAI” provides corporate advisory services including but not limited to private-to-public listing strategy, mergers and acquisition deal structuring consultation, up-valuation and up-listing of undervalued companies. About Boustead & Company Limited Boustead & Company Limited is a diversified financial services firm headquartered in Irvine, CA with offices in Austin, Boca Raton, San Francisco, New York, Beijing, London, Mauritius, Monaco, Singapore, and Zug. Boustead & Company Limited and its affiliates offer mergers & acquisitions, capital markets, project finance, pre-transaction advisory, financial restructuring, sales & trading, crowdfunding, and business valuation services to emerging growth and middle-market companies. About Raffles Capital US Raffles Capital US acts as venture-accelerator for promising firms that are ready and qualifies for a public listing on a North-America bourse within 18-24 months of vesting. RC works with companies that can deliver social impact bringing prosperity and progress to the people and planet. These firms’ purpose must be in alignment with the UN 17 Sustainable Development Goals. 立即发布 Boustead APEX, Inc. (宝德亚太) 在深圳接连举办第二场IPO大会探讨亚洲企业如何轻松进入全球最大资本市场 中国深圳 — 2025 年 8 月 11 日 — Boustead APEX Inc. 联合 万亿集团 成功举办 IPO 大会，吸引了来自深圳的逾 80 家高成长企业，共同探讨赴美资本市场的最佳路径。 大会重点展示了 Boustead APEX 如何帮助企业轻松进入全球最大资本市场——纽交所（NYSE）和纳斯达克（NASDAQ），并明确了主板上市的关键条件：400 名股东与 75 万美元利润。 美国 Boustead & Co 董事长 Keith Moore 表示： “凭借 Boustead 的专业经验，企业可以以清晰、自信、高效的方式进入美国市场。我们的目标是让上市过程更直接，同时实现估值最大化并保留创始人股权。” Boustead APEX 首席执行官 陳琛傑博士 补充道： “与万亿集团的合作让我们能直接与深圳最具雄心的企业建立联系。通过这一平台，我们将为更多中国企业打开通往美国主板市场的大门，赢得全球投资者的关注与高估值。” Boustead APEX 还分享了 一体化上市路线，帮助企业在 18–24 个月内，从盈利阶段迈向 OTCQB、纳斯达克或纽交所上市。 前瞻性声明 本新闻稿包含前瞻性声明，包括供应链金融的潜在效益、可能的估值结果及赴美上市的预估时间表。这些声明基于管理层当前的预期，存在导致实际结果出现重大差异的风险与不确定性。不能保证任何特定结果一定实现。影响结果的因素包括市场状况、监管批准、公司财务表现及公司披露文件中列明的其他风险。读者不应对前瞻性声明过度依赖，并应咨询专业顾问。 媒体联络： Faralynn Wong 宝德亚太公司 mani@bousteadapex.com 关于宝德亚太（Boustead APEX, Inc.） 宝德亚太及其附属公司专注于帮助高速成长的亚洲企业通过战略性上市、并购咨询及融资解决方案进入美国资本市场。 关于宝德投行（Boustead and Company） 宝德投行是美国领先的投资银行与承销商，在2024年被评为最大中小盘承销商。 关于美国莱福士资本（Raffles Capital US） 美国莱福士资本是一家专注于高影响力、可持续发展的私人投资集团，担任精选IPO及全球扩张项目的基石投资者。 Media Report: Boustead APEX, Inc. (宝德亚太) 在深圳接连举办第二场IPO大会探讨亚洲企业如何轻松进入全球最大资本市场 1、中金在线：http://hy.stock.cnfol.com/hangyejingcui/20250820/31561479.shtml 2、界面新闻：https://www.jiemian.com/article/13206248.html 3、财经网：http://industry.caijing.com.cn/20250820/5108270.shtml 4、全景网：https://www.p5w.net/roll/finance/202508/t20250820_6386045.htm 5、环球财富网：http://www.hqcf.com.cn/all_column_article/zixun/2025082030300.html 6、凤凰财经：https://finance.ifeng.com/c/8lyKPeZxbb0 7、证券之星：https://finance.stockstar.com/IG2025082000021918.shtml 8、投资家：http://www.investorscn.com/2025/08/20/123170/

FOR IMMEDIATE RELEASE Emperor Tea to Pursue U.S. IPO with Advisory Support from Boustead APEX — Taking Its Brand Global Shenzhen, China — 11 Aug 2025 — Emperor Tea has announced plans to pursue an Initial Public Offering (IPO) in the United States, a major step in its mission to globalise its brand — including entering the U.S. market — and bring the natural herbal goodness of tea to consumers worldwide. The company will be advised by Boustead APEX, Inc., with Boustead & Company serving as lead underwriter and Raffles Capital US participating as a cornerstone partner. The proposed IPO will underpin Emperor Tea’s growth strategy, which includes expanding market reach across North America, Europe, and Asia-Pacific, strengthening operational capacity, and developing innovative product lines that blend traditional Chinese tea craftsmanship with modern preferences. Access to U.S. capital markets is expected to provide the resources necessary to accelerate these initiatives. Dr. Marcuz Tan, CEO of Boustead APEX, Inc., said: “Our role is to provide the strategic and regulatory guidance necessary for a successful listing. We look forward to supporting Emperor Tea through each stage of the process as it scales globally.” Keith Moore, Executive Chairman of Boustead & Company, added: “We will work closely with Emperor Tea to prepare the company for entry into the U.S. markets, ensuring it meets the standards required for a public offering and is well-positioned for international investor interest.” Alice Tang, CEO of Emperor Tea, commented: “This IPO marks a defining chapter in our corporate journey. With the professional support of Boustead APEX, Boustead & Company, and Raffles Capital US, we aim to position Emperor Tea as a global leader in premium teas, sharing the natural herbal goodness of our products with tea lovers everywhere.” Dr. Charlie In, Founder of Raffles Capital US, remarked: “Raffles Capital is proud to serve as a cornerstone investor in Emperor Tea’s journey to the U.S. public markets. The company’s rich brand heritage, commitment to quality, and ambition to bring the benefits of natural herbal teas to a global audience make it an attractive and promising opportunity for investors.” Forward-Looking Statements This release contains forward-looking statements, including potential benefits of supply chain finance, possible valuation outcomes, and indicative timelines for U.S. listings. These statements are based on management’s current expectations and involve risks and uncertainties that could cause actual results to differ materially. No assurance can be given that any particular result will be achieved. Factors that could affect outcomes include market conditions, regulatory approvals, the company’s financial performance, and other risks described in company disclosures. Readers should not place undue reliance on forward-looking statements and should consult qualified professional advisors. About Boustead APEX, Inc. Boustead APEX, Inc. advises companies in Asia on accessing U.S. capital markets, providing services in IPO planning, uplisting, mergers and acquisitions, and corporate finance. About Boustead & Company Limited Boustead & Company Limited is a diversified financial services firm headquartered in Irvine, CA with offices in Austin, Boca Raton, San Francisco, New York, Beijing, London, Mauritius, Monaco, Singapore, and Zug. Boustead & Company Limited and its affiliates offer mergers & acquisitions, capital markets, project finance, pre-transaction advisory, financial restructuring, sales & trading, crowdfunding, and business valuation services to emerging growth and middle-market companies. About Raffles Capital US Raffles Capital US acts as venture-accelerator for promising firms that are ready and qualifies for a public listing on a North-America bourse within 18-24 months of vesting. RC works with companies that can deliver social impact bringing prosperity and progress to the people and planet. These firms’ purpose must be in alignment with the UN 17 Sustainable Development Goals. About Emperor Tea Emperor Tea is a premium tea company headquartered in China, producing and distributing a range of teas sourced from domestic plantations. Combining traditional production methods with modern operational practices, the company is committed to introducing the natural herbal goodness of tea to consumers worldwide. 即时发布 黄帝茶铺拟赴美上市 迈向全球化品牌发展——将天然草本茶的健康之道带向世界 中国深圳 — [2025年8月11日] — 黄帝茶铺正式宣布计划赴美国进行首次公开募股（IPO），这是公司实现品牌全球化的重要一步，包括进军美国市场，把天然草本的健康精华融入茶饮文化，分享给全球消费者。本次上市将由宝德亚太有限公司（Boustead APEX Inc.）担任战略顾问，宝德投行（Boustead and Company）担任主承销商，美国莱福士资本（Raffles Capital US）作为基石投资者参与其中。 计划中的IPO将为黄帝茶铺的全球增长战略提供坚实的资本支持。战略重点包括拓展北美、欧洲及亚太地区的市场版图，提升生产及运营能力，并推出兼具中国传统制茶工艺与现代消费趋势的创新茶产品。借助美国资本市场的融资平台，公司将加快推进这些关键计划。 宝德亚太有限公司首席执行官陈琛傑博士表示： “我们的使命是为皇茶提供成功上市所需的战略及合规指导，协助其在全球扩张的过程中稳步前行。” 宝德投行董事长 Mr Keith Moore 先生补充说： “我们将与皇茶紧密合作，确保公司顺利进入美国市场，满足上市所需的各项标准，并赢得国际投资者的关注。” 黄帝茶铺首席执行官唐程 女士表示： “本次IPO是公司发展历程中的重要里程碑。在宝德亚太、宝德投行以及美国莱福士资本的专业支持下，我们将努力把皇茶打造成全球高端茶品牌，让天然草本茶的健康之道走进世界各地消费者的生活。” 美国莱福士资本创始人殷生博士表示： “莱福士资本很荣幸能成为皇茶赴美上市之旅的基石投资者。黄帝茶铺拥有深厚的品牌底蕴、对品质的执着以及将天然草本茶健康理念推广至全球的宏伟愿景，这些都使其具备吸引全球投资者的独特优势。” 前瞻性声明 本新闻稿包含前瞻性声明，包括供应链金融的潜在效益、可能的估值结果及赴美上市的预估时间表。这些声明基于管理层当前的预期，存在导致实际结果出现重大差异的风险与不确定性。不能保证任何特定结果一定实现。影响结果的因素包括市场状况、监管批准、公司财务表现及公司披露文件中列明的其他风险。读者不应对前瞻性声明过度依赖，并应咨询专业顾问。 媒体联络： Faralynn Wong 宝德亚太公司 mani@bousteadapex.com 关于黄帝茶铺 黄帝茶铺是一家总部位于中国的茶饮企业，生产并销售源自国内优质药食同源的多种养生茶饮。公司秉承传统工艺，并结合现代化运营理念，致力于将天然草本的健康价值带给全球消费者。 关于宝德亚太有限公司（Boustead APEX, Inc.） 宝德亚太有限公司为亚洲企业提供进入美国资本市场的顾问服务，包括IPO规划、转板上市、并购以及企业融资等综合方案。 关于宝德投行（Boustead and Company） 宝德投行是一家美国注册的证券经纪商，提供投资银行服务，包括公开发行、私募融资及为国际企业提供上市顾问支持。 关于美国莱福士资本（Raffles Capital US） 美国莱福士资本投资并支持具有全球市场潜力的新兴企业，助力其实现可持续增长与价值提升。 Media Report: 黄帝茶铺拟赴美上市 迈向全球化品牌发展——将天然草本茶的健康之道带向世界 1、 中金在线：http://news.cnfol.com/shangyeyaowen/20250819/31558934.shtml 2、 财经网：http://industry.caijing.com.cn/20250819/5108099.shtml 3、 和讯新闻：http://news.hexun.com/2025-08-19/220992223.html 4、 界面新闻：https://www.jiemian.com/article/13201687.html 5、 凤凰财经：https://finance.ifeng.com/c/8lwrOClJCNk 6、 中国财富网：https://www.cfbond.com/2025/08/19/991098087.html 7、 新浪财经：https://finance.sina.cn/2025-08-19/detail-infmpiza1159885.d.html 8、 证券之星：https://finance.stockstar.com/IG2025081900029905.shtml

FOR IMMEDIATE RELEASE Boustead APEX Shenzhen IPO Conference Showcases Supply Chain Finance as a Game-Changer for High-Valuation U.S. Listings Shenzhen, China — 12 Aug 2025 — Boustead APEX, Inc. kicked off its inaugural China-wide IPO Conference in Shenzhen, the first of multiple city stops that will also include Beijing, Shanghai, and Hangzhou, bringing together entrepreneurs, investors, and market experts to share strategies for profitable growth and stronger positioning for U.S. capital market listings — while preserving founder equity. The event spotlighted supply chain finance as a powerful tool to provide companies with working capital to fulfill confirmed sales orders. By converting orders into immediate cash flow, businesses can accelerate revenue growth, generate profits, and strengthen their position for high price-to-earnings (P/E) multiples and market capitalizations upon listing. “Our mission is to empower founders to scale without losing control,” said Dr. Marcuz Tan (陳琛傑博士), CEO of Boustead APEX Inc. “Through supply chain finance, companies can boost profitability and position themselves for a significantly higher IPO valuation.” Angela Ye (葉晨), Executive Director of Astra Capital, added: “We advise on effective goods procurement to achieve positive cash flow and sustainable profitability — the foundation for higher P/E ratios and stronger market capitalization.” Li Jing (李靜), CEO of Regen Health Care Group, affirmed: “Adopting supply chain finance enhances our cash flow management, optimizes operations, and positions us for a high-valuation listing in the U.S.” Boustead APEX also presented its integrated advisory roadmap — aiming to guide companies from profitability to U.S. listings on OTCQB, NASDAQ, or NYSE within an estimated 18–24 months. Key Takeaways: •Build revenues without diluting founder equity. •Use supply chain finance to fund growth and drive profits. •Translate operational success into a high-valuation public listing. The Shenzhen conference reinforced Boustead APEX’s role in bridging Asia’s high-growth firms to the world’s largest capital markets while preserving founder ownership and maximizing returns. Forward-Looking Statements This release contains forward-looking statements, including potential benefits of supply chain finance, possible valuation outcomes, and indicative timelines for U.S. listings. These statements are based on management’s current expectations and involve risks and uncertainties that could cause actual results to differ materially. No assurance can be given that any particular result will be achieved. Factors that could affect outcomes include market conditions, regulatory approvals, the company’s financial performance, and other risks described in company disclosures. Readers should not place undue reliance on forward-looking statements and should consult qualified professional advisors. Media Contact: Faralynn Wong Boustead APEX, Inc. mani@bousteadapex.com About Boustead APEX, Inc. Boustead APEX, Inc. “BAI” provides corporate advisory services including but not limited to private-to-public listing strategy, mergers and acquisition deal structuring consultation, up-valuation and up-listing of undervalued companies. About Astra Capital Astra Capital provides online financial tools for global companies with trade finance advisory and funding arrangement services to help them grow their business. Astra Capital’s services range from issuance of letters of credit, bank guarantee, performance bond, pre-IPO funding, online crowdfunding, key-man universal life insurance, business credit/debit cards, asset digitalisation, e-wallet, e-vault, real estate investment trust, investment fund, issuance of public-listed companies’ B.O.S.S. (Bonds, Options, Shares & Structured-notes) and equities-backed financing. About Regen Health Care Group Regen Health Care Group is a leading provider of stem cell regeneration therapy, offering scientifically validated treatments designed to restore and repair damaged tissues and improve quality of life. Based in Shenzhen, China, Regen serves patients across Asia and is committed to advancing research in regenerative medicine. 即时发布 宝德亚太深圳IPO大会聚焦供应链金融——助力企业实现高估值赴美上市 中国·深圳 — 2025年8月12日 — 宝德亚太公司在深圳成功举办首届中国巡回IPO大会的首站活动。该大会还将陆续在北京、上海和杭州举办，汇聚了企业家、投资人及市场专家，共同探讨如何在保持创始人股权的前提下，实现企业盈利增长并提升赴美资本市场上市竞争力。 本次大会重点介绍了“供应链金融”这一重要工具，帮助企业获得履行已确认销售订单所需的营运资金。通过将订单转化为即时现金流，企业可加速营收增长、提升盈利能力，并在上市时获得更高的市盈率（P/E）和市值。 宝德亚太凭借其专业实力、成熟的资本市场网络及丰富的国际IPO经验，成为中国企业赴美上市的首选合作伙伴。公司在跨境合规、投资者对接和市场定位方面提供全面指导，为中国企业高效、稳健地迈入全球资本市场铺平道路。 宝德亚太公司首席执行官陈琛傑博士（Dr. Marcuz Tan）表示： “我们的使命是帮助创始人在不失去控制权的情况下，实现企业规模化。通过供应链金融，企业可以显著提升盈利能力，并为更高的IPO估值做好准备。” Astra Capital执行董事叶晨（Angela Ye）指出： “我们为企业提供高效采购建议，实现正向现金流与可持续盈利，这正是提升市盈率和市值的基石。” Regen Health Care Group首席执行官李靜（Li Jing）补充道： “引入供应链金融不仅改善了我们的现金流管理，还优化了运营效率，为在美国实现高估值上市奠定了坚实基础。” 宝德亚太在大会上还发布了其一体化顾问路线图，计划在18–24个月内，引导企业从盈利走向赴美OTCQB、纳斯达克或纽交所上市。 大会要点： •在不稀释创始人股权的前提下提升营收； •利用供应链金融支持企业增长并推动盈利； •将运营成果转化为高估值上市表现。 深圳站会议进一步巩固了宝德APEX在助力亚洲高增长企业进入全球最大资本市场、同时保留创始人股权并最大化回报方面的核心地位。 前瞻性声明 本新闻稿包含前瞻性声明，包括供应链金融的潜在效益、可能的估值结果及赴美上市的预估时间表。这些声明基于管理层当前的预期，存在导致实际结果出现重大差异的风险与不确定性。不能保证任何特定结果一定实现。影响结果的因素包括市场状况、监管批准、公司财务表现及公司披露文件中列明的其他风险。读者不应对前瞻性声明过度依赖，并应咨询专业顾问。 媒体联络： Faralynn Wong 宝德亚太公司 mani@bousteadapex.com 关于宝德亚太有限公司 宝德亚太公司及其附属机构专注于协助高增长的亚洲企业，通过战略上市、并购顾问及资本筹集方案进入美国资本市场。 关于 宝德投行（Boustead and Company） Boustead and Company 是一家投资银行，向各行业客户提供IPO、并购、资本募集及重组顾问服务。 关于莱福士资本（Raffles Capital US） Raffles Capital US是一家专注于高影响力、可持续项目的私人投资集团，并作为特定IPO及全球扩张项目的基石投资者。 关于Regen Health Care Group Regen Health Care Group是干细胞再生疗法领域的领先提供者，提供经科学验证的治疗方案，以修复和再生受损组织并提升生活质量。集团总部位于中国深圳，服务覆盖亚洲多个国家，并致力于推动再生医学领域的科研发展。 Media Report: 宝德亚太深圳IPO大会聚焦供应链金融——助力企业实现高估值赴美上市 1、界面新闻：https://www.jiemian.com/article/13193084.html 2、凤凰财经：https://finance.ifeng.com/c/8lv6gnk04G4 3、证券之星：https://finance.stockstar.com/IG2025081800015920.shtml 4、和讯新闻：https://news.hexun.com/2025-08-18/220964616.html 5、财经网：http://industry.caijing.com.cn/20250818/5107821.shtml 6、中金在线：http://hy.stock.cnfol.com/hangyejingcui/20250818/31554918.shtml 7、新浪财经：https://finance.sina.com.cn//jjxw//2025-08-18//doc-infmmezw9779766.shtml 8、中国财富网：https://www.cfbond.com/2025/08/18/991097170.html Boustead APEX, Inc. Boustead APEX, Inc. (BAI) is majority own by Boustead & Company Limited, and offers comprehensive corporate advisory services, including private-to-public listing strategies, mergers and acquisitions consultation, and up-valuation and up-listing support for undervalued companies. Media Contact: Faralynn Wong Email: faralynn@bousteadapex.com Website: www.bousteadapex.com

FOR IMMEDIATE RELEASE Singapore, 30 June 2025 – Raffles Capital Pte. Ltd. (“RC”) and Raffles Financial Group Limited (“RFG”) issue this official statement in response to recent incidents of false advertising and misrepresentation. We state unequivocally that RC and RFG have never conducted any form of fundraising activities in China, nor have we authorized any third party to carry out such activities on our behalf in China. Any claims to the contrary are false and misleading to the public. In recent months, we have identified several instances of unauthorized and deceptive use of our corporate name, which have resulted in reputational harm to our group. We urge the public to exercise caution and vigilance. If you encounter suspicious messages or unauthorized solicitations claiming affiliation with our group, please report them immediately to the relevant authorities. In the interest of transparency, we clarify that Raffles Financial Group Limited is majority- and controlling-owned by Raffles Capital Pte. Ltd., a company incorporated in Singapore. Raffles Capital was co-founded by Mr. Charlie In Nany Sing and Ms. Abigail Zhang Liying, both of whom continue to serve in strategic leadership roles within the group. We also wish to highlight our group’s international collaboration initiatives. Boustead APEX, Inc. (BAI) is a joint venture between Boustead & Company Limited (BCL) and Raffles Capital (RC), established to support ASEAN businesses—including those in China—in accessing global capital markets. Through BAI, we offer bespoke services such as Initial Public Offerings (IPOs), Over-the-Counter (OTC) listings, Real-World Asset (RWA) structures, and Real-Yield Asset (RYA) strategies, targeting markets in the United States, Oceania, and Singapore. RC and RFG remain steadfast in our commitment to integrity, transparency, and full regulatory compliance, and we will continue to provide trusted financial solutions to clients around the world. Media Contact: Corporate Communications Department Raffles Capital Pte. Ltd. Email: info@rafflescapital.us Website: www.rafflescapital.us

Singapore – 12 March 2025 – Boustead APEX, Inc. (BAI), a premier financial advisory firm, has solidified its position as one of the go-to IPO advisor for Asian companies (spanning ASEAN, Japan, Korea, and Greater China) seeking listings on leading U.S. exchanges, including the NYSE and NASDAQ. Their positioning is powered by Boustead & Company Limited, through its top-ranked U.S.-based underwriters, Boustead Securities, LLC and Sutter Securities, Inc (Boustead). With Asia-Pacific’s economic growth fueling cross-border capital market ambitions, BAI’s expertise bridges regional enterprises with global investors, offering end-to-end advisory services for seamless transitions to public markets. Its deep-rooted understanding of regulatory frameworks, investor expectations, and market dynamics positions BAI as a catalyst for Asian companies aiming to unlock value on the world stage. IPO Conference – Asia Edition 2025: Empowering Asia’s Next Generation of Public Companies BAI is spearheading the IPO Conference – Asia Edition 2025, a landmark event series designed to demystify the IPO journey for Asia-Pacific businesses. These conferences serves as a dynamic platform for CEOs, investors, legal experts, auditors, and underwriters to share actionable strategies for navigating U.S. listings. Attendees will benefit from the expertise of leading industry professionals, seasoned underwriters, legal experts, auditors, and advisors, exploring opportunities and addressing challenges across prominent exchanges like the NYSE and Nasdaq. The inaugural event in Singapore on January 17th was an overwhelming success, featuring a distinguished lineup of veteran US IPO underwriters, lawyers, auditors, and advisors. Building on this momentum, the next conference will be held in Hong Kong on March 5th. “We are thrilled to bring our expertise and resources to the vibrant Asian markets,” said Dr. Marcuz Tan, CEO of Boustead APEX, Inc. “With the support of the US-based Boustead and Singapore-based Raffles Capital, we are uniquely positioned to guide companies through the IPO process and unlock their full potential. The IPO Conference – Asia Edition 2025 is a testament to our commitment to fostering growth and innovation in the region.” “Asia-Pacific is a powerhouse of innovation and growth, and Boustead is proud to partner with Boustead APEX to bring these dynamic companies to the global stage. With our proven track record in US IPOs and BAI’s deep regional expertise, we are uniquely positioned to unlock opportunities for companies to access capital, expand their reach, and achieve their full potential on the world’s most prestigious exchanges.” Keith Moore, Boustead’s Executive Chairman Key Highlights: BAI Selected as Premier IPO Advisor: Focusing on the NYSE and NASDAQ listings for Asian companies (ASEAN, Japan, Korea, and Greater China). Strategic Backing: Powered by Boustead and its affiliates as a leading US-based small-cap underwriter. IPO Conference – Asia Edition 2025: A series of events designed to educate and connect businesses, investors, and IPO experts. Expert Insights: Featuring industry-leading speakers, seasoned professionals, and essential stakeholders. Global Market Access: Exploring opportunities and addressing challenges within the NYSE, and Nasdaq, and other prominent exchanges. Successful Singapore Launch: Overwhelmingly positive response from the inaugural event on January 17th. Upcoming Hong Kong Conference: March 5th, 2025. Followed by Malaysia Conference in April, and other Asian markets throughout 2025. Registration: Interested parties can register for the Hong Kong conference at: https://www.astracapital.asia/ipoconference About Boustead APEX, Inc. (BAI): Boustead APEX, Inc. (BAI) is a leading IPO advisory firm specializing in guiding Asian companies through the complexities of public listings on the NYSE and NASDAQ exchanges. Backed by US-based Boustead & Company Limited and Singapore-based Raffles Capital, BAI provides comprehensive support and access to global capital markets. For more information, please visit www.bousteadapex.com. About Boustead & Company Limited Boustead & Company Limited is a diversified financial services firm headquartered in Irvine, CA, with offices in Austin, Boca Raton, San Francisco, New York, Beijing, London, Mauritius, Monaco, Singapore, and Zug. Boustead & Company Limited and its affiliates offer mergers & acquisitions, capital markets, project finance, pre-transaction advisory, financial restructuring, sales & trading, crowdfunding, and business valuation services to emerging growth and middle-market companies. Media Contact Company Name: Boustead APEX, Inc Contact Person: Faralynn Wong Email: ir@bousteadapex.com Phone: +6583621332 Country: Singapore Website: https://www.bousteadapex.com

BAI's cornerstone investor Raffles Capital announces USD 10Bn SDG Impact Fund Hong Kong, March 10, 2025 — In a landmark collaboration, the United States-incorporated Raffles SDG Fund and Tai Chuang Yuan Group (TCY) have announced the launch of the SDG Impact Fund (SIF), a groundbreaking initiative aimed at supporting Asian companies aligned with the United Nations’ 17 Sustainable Development Goals (SDGs). The fund will specifically target companies poised to qualify for a US Initial Public Offering (IPO) within the next 24 months, providing them with the capital and resources needed to scale their impact-driven businesses. Driving Sustainable Growth and Impactful Investment The SDG Impact Fund (SIF) will invest in companies whose missions and operations align with the SDGs, focusing on delivering products and services that promote peace, prosperity, and planetary preservation. By bridging the gap between sustainable development and capital markets, SIF aims to accelerate the growth of businesses that are not only financially viable but also socially and environmentally transformative. Raffles SDG Fund, established by the founders of Raffles Capital Limited as a non-profit entity, is dedicated to building, managing, and allocating funds to organizations that drive meaningful change for people and the planet. Raffles Capital, a diversified financial services group, brings extensive expertise in corporate finance advisory, venture acceleration, public and private listing consultations, investor relations, private banking, and wealth management, including life insurance brokerage. Tai Chuang Yuan Group (TCY), with its roots in Taiwan, has a proven track record in managing 62 agriculture and incubation farms across China. TCY specializes in investments and projects related to food security, supply chain optimization, environmental enhancements, renewable energy, waste-to-wealth technologies, and healthcare. Their deep industry knowledge and commitment to sustainable development make them an ideal partner for this initiative. A Force for Good Dr. Charlie In, representing Raffles Capital, emphasized the transformative potential of the fund: “By combining the resources, expertise, and experience of TCY and Raffles Capital, SIF has the potential to be a powerful force for good—good for people and good for the planet. We are committed to investing in companies that can deliver significant positive impact, driving both social and environmental progress.” Dr. Linda Lee of Tai Chuang Yuan Group highlighted the fund’s focus on agriculture and sustainability: “Agriculture is the foundation of human civilization, and SIF is designed to empower farmers and farming communities by investing in advanced techniques and technologies. From recycling agricultural waste to optimizing supply chains and reducing carbon footprints, SIF will prioritize investments that enhance productivity, profitability, and sustainability.” Unlocking Capital for Sustainable Ventures SIF is uniquely positioned to act as a mother fund, supporting countries, communities, provinces, trade associations, and cooperatives in raising capital for their SDG-aligned projects and ventures. The fund will assist these entities in issuing B.O.S.S. (Bonds, Options, Shares, Structured-notes), enabling them to secure the necessary funding to grow and scale their initiatives. This partnership between Raffles SDG Fund and Tai Chuang Yuan Group marks a significant step forward in aligning capital markets with the global sustainability agenda. By empowering SDG-aligned companies to access public markets, SIF aims to create a ripple effect of positive change across Asia and beyond. For media inquiries, please contact: Tiffany Chai Email: tiffany@apexcapital.asia About Raffles SDG Fund: Raffles SDG Fund is a non-profit entity established by the founders of Raffles Capital Limited. It is dedicated to building, managing, and allocating funds to organizations that drive positive social and environmental impact in alignment with the United Nations’ Sustainable Development Goals. About Tai Chuang Yuan Group (TCY): Originating from Taiwan, TCY specializes in agriculture, food security, renewable energy, waste-to-wealth technologies, and healthcare. With a portfolio of 62 agriculture and incubation farms in China, TCY is committed to advancing sustainable development through innovative investments and projects. About SDG Impact Fund (SIF): The SDG Impact Fund (SIF) is a collaborative initiative between Raffles SDG Fund and Tai Chuang Yuan Group. It aims to invest in SDG-aligned Asian companies preparing for US IPOs within the next 24 months, providing them with the capital and resources needed to scale their impact-driven businesses. Contact Info: Name: Tiffany Chai Email: tiffany@apexcapital.asia Organization: SDG Impact Fund (SIF) Website: http://apexcapital.asia

Fantastic gathering of investors and businesses at the inaugural Sustainable Innovation & Investment Gala (S2iG), chaired by His Royal Excellency Dr Mohammad Khalifa UAE. Dr. Charlie In and Dr. Marcuz Tan are part of the spotlight of intersection of sustainability, innovation, and investment. A special thanks to Dr. Sharmila and Jerry Tan for the invitation! https://www.linkedin.com/feed/update/urn:li:activity:7255874464461029376/?actorCompanyId=90653910 #sdg #sustainable #rafflescapital #bousteadsecurities #investment #capital #innovation

Asia Biofuel Corporation (ABC) is tackling one of the most critical challenges of our time: sustainable energy. Specializing in the production of biofuels from organic materials, ABC is making strides toward offering an eco-friendly alternative to fossil fuels. Focused on the rapidly growing Asian market, particularly Vietnam, the company is working to address energy demand while reducing environmental impact. ABC’s strategic plans aim to streamline production processes and scale operations, allowing the company to capitalize on the growing demand for renewable energy solutions. By investing in ABC, you’re not just backing a company—you’re supporting a vision for a cleaner, more sustainable future. Discover the potential of biofuel investments by exploring Asia Biofuel Corporation on Boustead APEX Exchange. https://exchange.bousteadapex.com/asiabiofuelcorporation

In today’s competitive business environment, finding the right talent is essential for long-term success. CharacterBank™ is redefining the hiring process by introducing Character Code™, an AI-powered character profiling tool that goes beyond traditional assessments. By focusing on core character traits, Character Code™ helps companies identify candidates who will not only excel in their roles but align seamlessly with organizational culture. This approach promises to reduce costly turnover and improve workplace productivity, making CharacterBank a trailblazer in AI-driven HR solutions. For investors, this is a rare opportunity to enter the fast-growing HR tech market, where CharacterBank’s proprietary technology positions it as a leader in revolutionizing talent acquisition. Learn how CharacterBank is setting a new standard for hiring by visiting Boustead APEX Exchange. https://exchange.bousteadapex.com/characterbank

Circle Climate Corporation (CCC) is on a mission to overhaul the recycling industry in the United States. Currently, the recycling rate for paper and cardboard hovers around 67%, but CCC believes it can drive that number to 100% with a pioneering approach. By establishing a network of smaller, efficient recycling plants, CCC is not only increasing the capacity for recycling but also doing so in a way that minimizes environmental harm. This model aims to reduce waste and boost profitability, making CCC an attractive investment opportunity for those interested in sustainable business models. With the growing demand for effective recycling solutions, CCC’s scalable approach holds significant promise for both environmental impact and financial growth. Get a closer look at how CCC is leading the way in recycling innovation on Boustead APEX Exchange. https://exchange.bousteadapex.com/circleclimatecorporation

As cyber threats continue to escalate, organizations need robust, innovative solutions to protect their digital assets. Cybernatics Technology Group Inc. (CTGI) provides just that, offering a military-grade cybersecurity platform that’s already gaining traction in North America and the Indo-Pacific regions. With a focus on safeguarding intangible assets, Cybernatics is strategically positioned in a digital economy where intellectual property protection is paramount. This U.S.-based company, supported by its Singapore counterpart, Cybernatics Pte Ltd, offers cutting-edge capabilities that cater to the growing cybersecurity needs of corporations globally. Investing in CTGI means supporting a company that is not only protecting today’s digital landscape but also securing future growth potential in a high-demand industry. Discover how Cybernatics is pioneering cybersecurity innovation on Boustead APEX Exchange. https://exchange.bousteadapex.com/cybernatics

As Mottainai KK prepares for a potential Tokyo Stock Exchange listing, it offers a compelling investment into a sustainable future and a circular economy model that turns waste into wealth. In a world increasingly focused on sustainability and environmental responsibility, Mottainai KK is making waves as a trailblazer in the waste-to-wealth sector. Translating to "too good to be wasted" in Japanese, Mottainai’s name speaks volumes about its mission: to transform waste into valuable resources and foster a circular economy that benefits both the planet and society. As the company positions itself for a potential listing on the Tokyo Stock Exchange (TSE), investors are paying attention to its unique approach, promising growth trajectory, and unwavering commitment to sustainable solutions. *A Visionary Approach to a Growing Opportunity* Formed to address the mounting waste and food security challenges of today, Mottainai KK focuses on converting waste into rich, usable resources. The company's founders bring deep expertise across sectors like waste-to-energy, farmland remediation, agro-biotechnology, and plastic replacement. Together, they’ve built a robust platform to address critical environmental issues while creating profitable opportunities for growth. Mottainai’s strategy aligns seamlessly with the United Nations Sustainable Development Goals (SDGs), particularly Goal 17, which emphasizes partnerships to achieve peace, prosperity, and progress for people and the planet. Guided by this ethos, Mottainai’s business model doesn’t just promise returns but also a positive environmental and social impact, making it an attractive prospect for ESG-conscious investors. *A Unique, Asset-Light Corporate Strategy* What sets Mottainai apart in the waste-to-wealth sector is its asset-light corporate strategy. Rather than investing heavily in property, plant, and equipment (PPE), Mottainai operates through partnerships with outsourced processing contractors (OPCs). These OPCs are responsible for planting, processing, and producing goods for Mottainai’s clients, primarily in Japan and Southeast Asia. Mottainai supports its OPCs by providing raw materials, feedstock, and state-of-the-art equipment. By doing so, it maintains a lean operation while giving its contractors the tools they need to meet high-quality production standards. This approach minimizes Mottainai’s operational risks and enhances scalability, creating an agile framework for future expansion. In addition to supplying the necessary resources, Mottainai enters into long-term, 10+10-year contracts with OPCs. These contracts are designed to foster stability and provide OPCs with the assurance of ongoing business, with Mottainai receiving a usage fee of 10% of sales revenue, paid quarterly. This structure creates a steady revenue stream and aligns the incentives of both parties, ensuring sustainable growth on all sides. *Preparing for TSE Listing and a USD 1 Million Capital Raise* As Mottainai sets its sights on a potential TSE listing, the company plans to raise USD 1 million by placing one million shares at USD 1 per share, with a minimum investment lot of USD 2,500. This initial capital will be critical to scaling its operations, activating its USD 10 million trade-finance facility, and supporting the company’s ambitious mission of turning waste into valuable resources. The funds will also help Mottainai grow its operational footprint, enhancing its procurement and production capabilities to serve the expanding demand for sustainable products in Japan and Southeast Asia. By supporting the purchase of additional raw materials and upgrading its contractor network, Mottainai ensures it can meet the requirements of its diverse clientele while staying true to its sustainability objectives. *Creating Tangible Value Through Sustainability* While profitability is undoubtedly a focus for Mottainai, the company is equally driven by a commitment to sustainability. By promoting a circular economy model, Mottainai offers a dual benefit: it turns discarded resources into value and reduces environmental impact at scale. Waste becomes wealth under Mottainai’s approach, as the company works to address the global waste crisis through innovative, responsible practices. For example, Mottainai’s work in farmland remediation and plastic replacement technologies showcases its commitment to tackling some of the world’s most pressing environmental issues. By converting waste into bio-based products and sustainable alternatives, Mottainai not only reduces waste but also supports food security initiatives, positively impacting communities across its target markets. *An Investment in the Future of Sustainability* Mottainai KK presents a rare investment opportunity—one that not only aims for financial returns but also promises to drive real-world impact. Investors interested in ESG principles and the transformative potential of the circular economy model will find Mottainai’s business and mission compelling. The company’s potential listing on the Tokyo Stock Exchange marks a new chapter for Mottainai and its stakeholders. With a clear vision, a proven asset-light strategy, and a strong commitment to sustainability, Mottainai KK is poised to become a leader in the waste-to-wealth sector. For more information on Mottainai’s journey and investment opportunities, visit [Company Website]. As the company moves toward its TSE listing and continues to expand its sustainable solutions, Mottainai KK offers investors a front-row seat to a more sustainable, prosperous future. https://mottainai.apexipo.info/

For Immediate Release Boustead APEX advises Mottainai, NetZero to IPO on Tokyo Stock Exchange for Sustainability Singapore – October 30, 2024 – Boustead Apex, Inc. (BAI) today announced its commitment to advancing the plans of two Singapore-based firms, Mottainai and NetZero, to pursue listings on the Tokyo Stock Exchange (TSE)—the world’s third-largest stock exchange, with a market capitalization exceeding USD 6 trillion. This decision follows the TSE’s IPO event held in Singapore on October 22, 2024, which promoted the listing of foreign companies on its exchange. Mottainai KK is in the waste-to-wealth circular economy, converting agricultural, municipal, and petroleum waste into sustainable energy, fertilizers, and biochar for the Japanese market. Driven by a mission to rehabilitate degraded farmland, Mottainai addresses soil toxicity and acidity to enhance crop productivity and quality. NetZero, a carbon credit creator, converts waste into green coal substitutes for Japan’s steelmakers and major power producers. In alignment with its carbon neutrality goals, NetZero aims to support Japan’s heavy coal users in reducing carbon emissions through green coal substitutes. “BAI has been instrumental in advising Mottainai and NetZero, facilitating strong support from the USD 10 billion SDG Impact Investment Consortium led by Raffles Capital,” said Dr. Marcuz Tan, CEO of Boustead APEX, Inc. The companies work closely with waste feedstock providers and specialized production contractors across Southeast Asia, with plans to supply recycled and repurposed products to Japan. Shipments are coordinated through prominent trading firms, including Mitsui, Itochu, Sumitomo, Marubeni, and Sojitz. Under the same parent company as Boustead Securities LLC — a USA leading small-cap IPO underwriter established since 2006—BAI provides strategic advisory support to Mottainai and NetZero. In collaboration with Mitsubishi UFJ Financial Group (MUFG), BAI is delivering IPO listing strategies and investor relations programs to position these issuers for success in the Japanese market. Boustead APEX, Inc. Boustead APEX, Inc. (BAI) is majority own by Boustead & Company Limited, and offers comprehensive corporate advisory services, including private-to-public listing strategies, mergers and acquisitions consultation, and up-valuation and up-listing support for undervalued companies. Media Contact: Faralynn Wong Email: faralynn@bousteadapex.com Website: www.bousteadapex.com